Integrative Proteomics-Metabolomics Strategy for Pathological Mechanism of Vascular Depression Mouse Model.

Vascular depression (VD), a subtype of depression, is caused by vascular diseases or cerebrovascular risk factors. Recently, the proportion of VD patients has increased significantly, which severely affects their quality of life. However, the current pathogenesis of VD has not yet been fully understood, and the basic research is not adequate. In this study, on the basis of the combination of LC-MS-based proteomics and metabolomics, we aimed to establish a protein metabolism regulatory network in a murine VD model to elucidate a more comprehensive impact of VD on organisms. We detected 44 metabolites and 304 proteins with different levels in the hippocampus samples from VD mice using a combination of metabolomic and proteomics analyses with an isobaric tags for relative and absolute quantification (iTRAQ) method. We constructed a protein-to-metabolic regulatory network by correlating and integrating the differential metabolites and proteins using ingenuity pathway analysis. Then we quantitatively validated the levels of the bimolecules shown in the bioinformatics analysis using LC-MS/MS and Western blotting. Validation results suggested changes in the regulation of neuroplasticity, transport of neurotransmitters, neuronal cell proliferation and apoptosis, and disorders of amino acids, lipids and energy metabolism. These proteins and metabolites involved in these dis-regulated pathways will provide a more targeted and credible direction to study the mechanism of VD. Therefore, this paper presents an approach and strategy that was applied in integrative proteomics and metabolomics for research and screening potential targets and biomarkers of VD, which could be more precise and credible in a field lacking adequate basic research.

[1]  Mariagiovanna Cantone,et al.  Motor cortex excitability in vascular depression. , 2011, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[2]  J. Krystal,et al.  Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond , 2013, Biological Psychiatry.

[3]  G. Fiskum Mitochondrial participation in ischemic and traumatic neural cell death. , 2000, Journal of neurotrauma.

[4]  Guoyao Wu,et al.  Amino acids: metabolism, functions, and nutrition , 2009, Amino Acids.

[5]  R. Nicoll,et al.  Long-term potentiation--a decade of progress? , 1999, Science.

[6]  Z. Lou,et al.  Metabonomic identification of the effects of the Zhimu-Baihe saponins on a chronic unpredictable mild stress-induced rat model of depression. , 2016, Journal of pharmaceutical and biomedical analysis.

[7]  H. Stassen,et al.  Mortality of patients with mood disorders: follow-up over 34-38 years. , 2002, Journal of affective disorders.

[8]  T. Südhof The synaptic vesicle cycle , 2004 .

[9]  E. Orenes-Piñero,et al.  High-resolution proteomics and metabolomics in thyroid cancer: Deciphering novel biomarkers , 2017, Critical reviews in clinical laboratory sciences.

[10]  S. Mitchell,et al.  Executive function deficits and glutamatergic protein alterations in a progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease , 2015, Journal of neuroscience research.

[11]  Haiyun Xu,et al.  Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice. , 2007, Life sciences.

[12]  K. Krishnan,et al.  Psychiatric Disease in the Twenty-First Century: The Case for Subcortical Ischemic Depression , 2006, Biological Psychiatry.

[13]  Haiyun Xu,et al.  Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice. , 2010, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[14]  Ruedi Aebersold,et al.  Targeted Proteomics of the Eicosanoid Biosynthetic Pathway Completes an Integrated Genomics-Proteomics-Metabolomics Picture of Cellular Metabolism* , 2012, Molecular & Cellular Proteomics.

[15]  Lanbing Yu,et al.  Comparative proteome analysis of saccular intracranial aneurysms with iTRAQ quantitative proteomics. , 2016, Journal of proteomics.

[16]  D. Arveiler,et al.  Depressive Symptoms, a Time-Dependent Risk Factor for Coronary Heart Disease and Stroke in Middle-Aged Men: The PRIME Study , 2012, Stroke.

[17]  R. Nicoll,et al.  Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins. , 2007, Trends in cell biology.

[18]  A. Rush,et al.  Hippocampal Remodeling and Damage by Corticosteroids: Implications for Mood Disorders , 1999, Neuropsychopharmacology.

[19]  E. Nestler,et al.  Hippocampal HDAC4 Contributes to Postnatal Fluoxetine-Evoked Depression-Like Behavior , 2014, Neuropsychopharmacology.

[20]  Xiaozhen Guo,et al.  Comparative Proteomics Analysis Reveals L-Arginine Activates Ethanol Degradation Pathways in HepG2 Cells , 2016, Scientific Reports.

[21]  N. Jaworska,et al.  A pilot study of hippocampal N-acetyl-aspartate in youth with treatment resistant major depression. , 2017, Journal of affective disorders.

[22]  V. Gudnason,et al.  Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study. , 2015, The American journal of psychiatry.

[23]  Javier García-Villafranca,et al.  Involvement of nitric oxide/cyclic GMP signaling pathway in the regulation of fatty acid metabolism in rat hepatocytes. , 2003, Biochemical pharmacology.

[24]  K. Kashiwagi,et al.  Modulation of cellular function by polyamines. , 2010, The international journal of biochemistry & cell biology.

[25]  J. Kong,et al.  Quetiapine regulates neurogenesis in ischemic mice by inhibiting NF-κB p65/p50 expression , 2009, Neurological research.

[26]  C. W. Tabor,et al.  Polyamines protect Escherichia coli cells from the toxic effect of oxygen , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[28]  J. Canales,et al.  Molecular mechanism of acute ammonia toxicity: role of NMDA receptors , 2002, Neurochemistry International.

[29]  D. Steffens,et al.  What are the causes of late-life depression? , 2013, The Psychiatric clinics of North America.

[30]  Mark von Zastrow,et al.  Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures , 1999, Nature Neuroscience.

[31]  P. Xie,et al.  Prolonged exposure to low-dose microcystin induces nonalcoholic steatohepatitis in mice: a systems toxicology study , 2016, Archives of Toxicology.

[32]  J. Sastre,et al.  Mitochondrial Oxidative Stress Plays a Key Role in Aging and Apoptosis , 2000, IUBMB life.

[33]  J. Gallo,et al.  Vascular depression prevalence and epidemiology in the United States. , 2012, Journal of psychiatric research.

[34]  G. Hankey,et al.  Depression as a risk factor for cognitive impairment in later life: the Health In Men cohort study , 2016, International journal of geriatric psychiatry.

[35]  P. Zuo,et al.  Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/c mice subjected to unpredictable chronic mild stress: Implications for depressive disorders and future therapies , 2011, Neurochemistry International.

[36]  W. Taylor,et al.  Epidemiology of MRI-defined vascular depression: A longitudinal, community-based study in Korean elders. , 2015, Journal of affective disorders.

[37]  D. Muller,et al.  Long-term potentiation is associated with an increased activity of Ca2+/calmodulin-dependent protein kinase II. , 1993, The Journal of biological chemistry.

[38]  K. Krishnan,et al.  The Vascular Depression Subtype: Evidence of Internal Validity , 2008, Biological Psychiatry.

[39]  B. Winblad,et al.  Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment. , 2012, Panminerva medica.

[40]  K. Kashiwagi,et al.  Independent roles of eIF5A and polyamines in cell proliferation. , 2005, The Biochemical journal.

[41]  E. Holmes,et al.  A Combined Metabonomic and Proteomic Approach Identifies Frontal Cortex Changes in a Chronic Phencyclidine Rat Model in Relation to Human Schizophrenia Brain Pathology , 2013, Neuropsychopharmacology.

[42]  J. Lisman,et al.  The molecular basis of CaMKII function in synaptic and behavioural memory , 2002, Nature Reviews Neuroscience.

[43]  W. Taylor,et al.  The vascular depression hypothesis: mechanisms linking vascular disease with depression , 2013, Molecular Psychiatry.

[44]  Daniela Popa,et al.  Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Kaste,et al.  Magnetic resonance imaging correlates of depression after ischemic stroke. , 2001, Archives of general psychiatry.

[46]  T. Südhof,et al.  RIM genes differentially contribute to organizing presynaptic release sites , 2012, Proceedings of the National Academy of Sciences.

[47]  K. Hashimoto Targeting of NMDA receptors in new treatments for schizophrenia , 2014, Expert opinion on therapeutic targets.

[48]  J. Sneed,et al.  The vascular depression hypothesis: an update. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[49]  S. Tsai Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[50]  S. Gygi,et al.  Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Villar,et al.  Integrated Metabolomics, Transcriptomics and Proteomics Identifies Metabolic Pathways Affected by Anaplasma phagocytophilum Infection in Tick Cells* , 2015, Molecular & Cellular Proteomics.

[52]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[53]  Alan Nelson,et al.  Cognitive Deficits Induced by Global Cerebral Ischaemia: Prospects for Transplant Therapy , 1997, Pharmacology Biochemistry and Behavior.

[54]  K. Hashimoto Emerging role of glutamate in the pathophysiology of major depressive disorder , 2009, Brain Research Reviews.

[55]  J J Kim,et al.  PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. , 1993, Cell.

[56]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[57]  J. Malsam,et al.  Interactions Between SNAP-25 and Synaptotagmin-1 Are Involved in Vesicle Priming, Clamping Spontaneous and Stimulating Evoked Neurotransmission , 2016, The Journal of Neuroscience.

[58]  E. Stern,et al.  Vascular depression: a new view of late-onset depression , 1999, Dialogues in clinical neuroscience.

[59]  S. Heinemann,et al.  Cloned glutamate receptors. , 1994, Annual review of neuroscience.

[60]  Ming Wang,et al.  Suppression of synaptic plasticity by fullerenol in rat hippocampus in vitro , 2016, International journal of nanomedicine.

[61]  W. Liu,et al.  Global liver proteome analysis using iTRAQ labeling quantitative proteomic technology to reveal biomarkers in mice exposed to perfluorooctane sulfonate (PFOS). , 2012, Environmental science & technology.

[62]  C F Stevens,et al.  Modified hippocampal long-term potentiation in PKC gamma-mutant mice. , 1993, Cell.

[63]  Yinghui Chen,et al.  γ-aminobutyric acid transporter-1 is involved in anxiety-like behaviors and cognitive function in knockout mice. , 2015, Experimental and therapeutic medicine.

[64]  Haiyun Xu,et al.  Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice , 2007, Behavioural Brain Research.

[65]  D. Alkon,et al.  Postischemic PKC activation rescues retrograde and anterograde long-term memory , 2009, Proceedings of the National Academy of Sciences.